Agenda of the CHMP meeting 14-17 October 2024
Agenda of the CHMP meeting 14-17 October 2024
Agenda of the CHMP meeting 14-17 October 2024
Veterinary medicines European public assessment report (EPAR): Versican Plus DHPPi/L4R, live, attenuated Canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus inactivated and Leptospira, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Aivlosin, tylvalosin, Status: Authorised
Public health threats
Veterinary medicines European public assessment report (EPAR): Porcilis PCV ID, Porcine circovirus vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Arti-Cell Forte, chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells, Status: Authorised
PSUSA/00009174/202402
PSUSA/00010865/202401
Human medicines European public assessment report (EPAR): Halaven, eribulin, Date of authorisation: 17/03/2011, Revision: 31, Status: Authorised
PSUSA/00002345/202312